Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC. | 3 Biotech | 2023 | 36540413 | PubTator, text mining | PubMed |
Leaky Gut Plays a Critical Role in the Pathophysiology of Autism in Mice by Activating the Lipopolysaccharide-Mediated Toll-Like Receptor 4-Myeloid Differentiation Factor 88-Nuclear Factor Kappa B Signaling Pathway. | Neurosci Bull | 2023 | 36528850 | PubTator, text mining | PubMed |
| Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. | J Allergy Clin Immunol | 2023 | 36522221 | PubTator, text mining | PubMed |
| Identification of galectin-1 and other cellular targets of alpha,beta-unsaturated carbonyl compounds, including dimethylfumarate, by use of click-chemistry probes. | Redox Biol | 2023 | 36493513 | PubTator, text mining | PubMed |
| Mechanisms and application strategies of miRNA‑146a regulating inflammation and fibrosis at molecular and cellular levels (Review). | Int J Mol Med | 2023 | 36484394 | PubTator, text mining | PubMed |
| Biallelic TLR4 deficiency in humans. | J Allergy Clin Immunol | 2023 | 36462956 | PubTator, text mining | PubMed |
| Biological drivers of clinical phenotype in myelofibrosis. | Leukemia | 2023 | 36434065 | PubTator, text mining | PubMed |
| Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia. | Am J Hematol | 2023 | 36415104 | PubTator, text mining | PubMed |
| The role of extracellular histones in COVID-19. | J Intern Med | 2023 | 36382685 | PubTator, text mining | PubMed |
| Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. | Mol Aspects Med | 2023 | 36371228 | PubTator, text mining | PubMed |
| Offspring affected with in utero Zika virus infection retain molecular footprints in the bone marrow and blood cells. | Emerg Microbes Infect | 2023 | 36369716 | PubTator, text mining | PubMed |
| Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis. | Cancer Chemother Pharmacol | 2023 | 36346454 | PubTator, text mining | PubMed |
| IRAK1 Duplication in MECP2 Duplication Syndrome Does Not Increase Canonical NF-κB-Induced Inflammation. | J Clin Immunol | 2023 | 36319802 | PubTator, text mining | PubMed |
| Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment. | Adv Biol Regul | 2023 | 36216757 | PubTator, text mining | PubMed |
| Inherited IRAK-4 Deficiency in Acute Human Herpesvirus-6 Encephalitis. | J Clin Immunol | 2023 | 36205835 | PubTator, text mining | PubMed |
| Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA. | J Innate Immun | 2023 | 35785771 | PubTator, text mining | PubMed |
| Intraocular Inflammation Associated with IRAK4 Deficiency. | Ocul Immunol Inflamm | 2023 | 35442872 | PubTator, text mining | PubMed |
| Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation. | Turk J Biol | 2022 | 37533513 | PubTator, text mining | PubMed |
| The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout. | J Rheum Dis | 2022 | 37475970 | PubTator, text mining | PubMed |
| TLR9 signalling activation via direct ligation and its functional consequences in CD4 + T cells. | Scand J Immunol | 2022 | 37406035 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=28